Teva Pharma (TEVA) SWOT Analysis

Teva Pharma (TEVA) SWOT Analysis


Low Cost Product Should do better in an economic recession since goods are priced low. Low cost provide significant...
Niche Market Leader A specific country or niche market leading position brings many benefits to those companies....
Diverse Business Diverse operations should shield a business during downturns in the economy. A stable business also...



Demographic Trends Favorable demographics favor this market. Health care and peripheral industries will continue to...
Fragmented Market A highly fragmented market will benefit companies, which have economies of scale and can provide the...


Political Risk Political risk increases the cost of doing business, especially in foreign territories. This risk...

Teva Pharma (TEVA) SWOT Analysis Profile

Teva Pharmaceutical Industries Limited is a developer and marketer of generic and human pharmaceuticals and active pharmaceutical ingredients in North America, Europe, Latin America, Asia, and Israel. The companys pharmaceutical products are designed for the treatment of various conditions including multiple sclerosis, Parkinsons disease, and respiratory ailments. The company also distributes active pharmaceutical ingredients for use in third-party respiratory products, anti-inflammatories, immunosuppressants, muscle relaxants, and more. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

SWOT Conclusion

Strengths + Opportunities = 6

Threats + Weaknesses = 5

… Maintaining strengths can help maintain high profits and low costs.

SWOT Analysis Survey